Elliott Management Statement on Nippon Express Holdings, Inc.

Elliott Management Statement on Nippon Express Holdings, Inc.

LONDON, May 20, 2026 /PRNewswire/ -- Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together own approximately 6% of Nippon Express Holdings, Inc. ("Nippon Express" or the "Company"), today...

Fujitsu, SMBC Group and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare

Fujitsu, SMBC Group and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare

Companies aim to extend healthy life expectancy, optimize management of healthcare institutions, and curb national healthcare costs Sumitomo Mitsui Financial Group, Inc. Fujitsu Limited SoftBank Corp. TOKYO, May 19, 2026 /PRNewswire/ -- Fujitsu...

Zeeco, Inc. Completes Acquisition of Oil & Gas Technologies, Expanding its Capabilities and Presence in Australia

Zeeco, Inc. Completes Acquisition of Oil & Gas Technologies, Expanding its Capabilities and Presence in Australia

TULSA, Okla., May 18, 2026 /PRNewswire/ -- Zeeco, Inc., a global leader in advanced combustion and environmental solutions, today announced it has finalized the acquisition of Oil & Gas Technologies, an Australia-based company specializing in...

China Automotive Systems Began Volume Shipment of EPS Systems to a Global Automaker in Europe

China Automotive Systems Began Volume Shipment of EPS Systems to a Global Automaker in Europe

WUHAN, China, May 18, 2026 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that the first batch of electric power steering...

Top Philippine Fintech Mynt Doubles QoQ Earnings

Top Philippine Fintech Mynt Doubles QoQ Earnings

Cements Role in Driving an Inclusive Digital Economy in the Southeast Asian Nation MANILA, Philippines, May 18, 2026 /PRNewswire/ -- Mynt, Inc., the parent company of the Philippines' number one finance superapp, GCash, continued to deliver...

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

HAIKOU, China, May 14, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual market...

Health In Tech Reports First Quarter 2026 Financial Results

Health In Tech Reports First Quarter 2026 Financial Results

Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla., May 14, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today...

Yum China Announces US$512 Million Share Repurchase Agreements for Second Half of 2026 as Part of US$1.5 Billion Full-Year Capital Return Plan

Yum China Announces US$512 Million Share Repurchase Agreements for Second Half of 2026 as Part of US$1.5 Billion Full-Year Capital Return Plan

SHANGHAI, May 12, 2026 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that it has entered into share repurchase agreements in the U.S. and Hong Kong for an aggregate repurchase amount of...

PowerX Signs MOU with Montenegro's National Utility EPCG for Strategic Cooperation on Battery Energy Storage

PowerX Signs MOU with Montenegro's National Utility EPCG for Strategic Cooperation on Battery Energy Storage

TOKYO, May 11, 2026 /PRNewswire/ -- PowerX, Inc.(Head Office: Tamano City, Okayama Prefecture; Director, President and CEO: Masahiro Ito; Securities Code: 485A) signed a Memorandum of Understanding (MOU) on May 7th with Elektroprivreda Crne Gore AD...

The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 57
  • menu
    menu